HEAD
 

   Home
   Research
   Publications
   Lab Personnel
   News
   Gallery

   Contact

 

News

Antigens by special delivery
Science-Business eXchangeo,27 march 2008 • VOLUME 1 / NUMBER 9
Separate research teams at caltech and rockefeller University have shown that directly targeting antigen to dendritic cells improves t cell response and enhances DNA vaccine efficacy compared with nontargeted approaches..more

 

Can Designer Immune Cells Stop AIDS?
FALL 2007 VITERBI.USC.EDU
Twenty years after its introduction, gene therapy still holds great promise as a way to harness the insidious power of viruses such as human immunodeficiency syndrome. But scientists have yet to solve a vexing problem: developing an efficient transport system that is capable of delivering therapeutic payloads to specific cells..more

 

Viral manoeuvres revealed by surveillance system
07 September 2008 NewScientist.com news service
Virologists have a new weapon in the war against viruses – a way to tag and track individual viruses that are too small to be viewed with light microscopes..more

 

Engineering immunity
October 4, 2008, IAVI Report
“We really ought to try heroic measures because we have nothing to lose,” says David Baltimore, a professor at the California Institute of Technology , referring to AIDS vaccine research.....more

 

Lentivector Targeting to Dendritic Cells
June 2008, Molecular Therapy vol. 16 no. 6
Development of effective vaccines for the immunotherapy of cancer or persistent infectious disease will require the reactivation of a suboptimal immune response; in the case of cancer immunotherapy this often involves breaking immunologic tolerance to self-antigens expressed by the tumor cells......more

 

Will Synthetically Engineered Immune Cells Stop AIDS?
June 2008, USC Viterbi School of Engineering News
Twenty years after its introduction, gene therapy still holds great promise as a way to harness the insidious power of viruses such as human immunodeficiency syndrome. But scientists have yet to solve a vexing problem: developing an efficient transport system that is capable of delivering therapeutic payloads to specific cells.......more




 


 
Last updated 11/14/08